All posts by : Felistas

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new AI-powered tool that analyzes multiple imaging types simultaneously, developed by an international team of researchers led by Monash University.

Researchers at the UCL Queen Square Institute of Neurology find that the hippocampus sends signals to the visual cortex to predict what we are about to see.

Imagine having to eat something that makes you sick—just to see what’s making you ill in the first place.

Fitness enthusiasts have debated the question for decades: is it better to do cardio before or after lifting weights? Until recently, the answer has largely been down to preference—with some enjoying a jog to warm up before hitting the weights, while others believe lifting first is better for burning fat.

A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver of microvascular obstruction in COVID-19, bypassing the expected role of fibrin and platelet clots.

Nurses deliver almost 80% of hands-on direct care globally, making them important in strengthening health system resilience. Despite their contributions during health crises, they remain underrepresented in leadership roles that shape essential resilience strategies.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune response.

As more of us live longer, can robots help us maintain healthier, more independent and dignified lives? The robots I’ve been studying are friendly, helpful machines that can talk, remind, monitor—and even offer a form of companionship for older people.

A few years ago, a student in my history of public health course asked why her mother couldn’t afford insulin without insurance, despite having a full-time job. I told her what I’ve come to believe: The U.S. health care system was deliberately built this way.

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes, according to researchers at the University of Toronto.